4.7 Review

DNA damage responses and p53 in the aging process

期刊

BLOOD
卷 131, 期 5, 页码 488-495

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2017-07-746396

关键词

-

资金

  1. Cologne Graduate School on Aging (CECAD-CGA)
  2. Deutsche Forschungsgemeinschaft (CECAD) [SFB 829, SFB 670, KFO 286]
  3. European Research Council [ERC 260383]
  4. Marie Curie Initial Training Network [ITN CodeAge 316354, aDDRess 316390, MARRIAGE 316964]
  5. FLAG-ERA JTC (G-Immunomics) [SCHU 2494/3-1]
  6. German-Israeli Foundation [GIF 1104-68.11/2010]
  7. Deutsche Krebshilfe [109453]
  8. Bundesministerium fur Bildung und Forschung [Sybacol FKZ0315893A-B]
  9. European Cooperation in Science and Technology (COST) action (GENiE) [BM1408]

向作者/读者索取更多资源

The genome is constantly attacked by genotoxic insults. DNA damage has long been established as a cause of cancer development through its mutagenic consequences. Conversely, radiation therapy and chemotherapy induce DNA damage to drive cells into apoptosis or senescence as outcomes of the DNA damage response (DDR). More recently, DNA damage has been recognized as a causal factor for the aging process. The role of DNA damage in aging and age-related diseases is illustrated by numerous congenital progeroid syndromes that are caused by mutations in genome maintenance pathways. During the past 2 decades, understanding how DDR drives cancer development and contributes to the aging process has progressed rapidly. It turns out that the DDR factor p53 takes center stage during tumor development and also plays an important role in the aging process. Studies in metazoan models ranging from Caenorhabditis elegans to mammals have revealed cell-autonomous and systemic DDR mechanisms that orchestrate adaptive responses that augment maintenance of the aging organism amid gradually accumulating DNA damage.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据